NDC 53877-010 Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm

Anticoagulant Citrate Phosphate Dextrose (cpd)

NDC Product Code 53877-010

NDC Code: 53877-010

Proprietary Name: Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm Additional informationCallout TooltipWhat is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Anticoagulant Citrate Phosphate Dextrose (cpd) Additional informationCallout TooltipWhat is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.


Code Structure
  • 53877 - Terumo Corporation
    • 53877-010 - Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm

NDC 53877-010-01

Package Description: 10 POUCH in 1 CARTON > 1 BAG in 1 POUCH > 70 mL in 1 BAG

NDC Product Information

Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm with NDC 53877-010 is a a human prescription drug product labeled by Terumo Corporation. The generic name of Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm is anticoagulant citrate phosphate dextrose (cpd). The product's dosage form is solution and is administered via intravenous form.

Labeler Name: Terumo Corporation

Dosage Form: Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.

Product Type: Human Prescription Drug Additional informationCallout TooltipWhat kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.


Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm Active Ingredient(s)

Additional informationCallout TooltipWhat is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • DEXTROSE MONOHYDRATE 1.79 g/70mL
  • TRISODIUM CITRATE DIHYDRATE 1.84 g/70mL
  • ANHYDROUS CITRIC ACID 209 mg/70mL
  • SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 156 mg/70mL

Inactive Ingredient(s)

Additional informationCallout TooltipAbout the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • WATER (UNII: 059QF0KO0R)

Administration Route(s)

Additional informationCallout TooltipWhat are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Intravenous - Administration within or into a vein or veins.

Pharmacological Class(es)

Additional informationCallout TooltipWhat is a Pharmacological Class?
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)

Product Labeler Information

Additional informationCallout TooltipWhat is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Terumo Corporation
Labeler Code: 53877
FDA Application Number: BN880217 Additional informationCallout TooltipWhat is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: NDA - A product marketed under an approved New Drug Application. Additional informationCallout TooltipWhat is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 02-11-2019 Additional informationCallout TooltipWhat is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 Additional informationCallout TooltipWhat is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N Additional informationCallout TooltipWhat is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm Product Label Images

Imuflex Wb-sp Blood Bag System With Integral Whole Blood Leukocyte Reduction Filter (saving Platelets) With Diversion Blood Sampling Arm Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Other

NDC 53877-010-01CPD SOLUTIONFor the collection of 500 mL of Whole BloodFULL PRESCRIBING INFORMATION*Sections or subsections omitted from the Full Prescribing Information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17].

MANUFACTURED BY:TERUMO CORPORATION44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU,TOKYO 151-0072, JAPAN    MADE IN JAPAN® : Registered Trademark© TERUMO CORPORATION December, 2018TERUMO is a trademark of TERUMO CORPORATION.DonorCare is a registered trademark of Noble House Group Pty. Ltd. CORPORATION.Issued 2018-12N-LCD506A6 2

1. Indications And Usage

1.1. Read these instructions carefully before use.1.2. Rx ONLY.1.3. Intended for the collection, processing and preservation of Whole Blood. Not intended for direct intravenous infusion.1.4. For the collection of 500 mL ±10% Whole Blood.1.5. Integral Diversion Blood Sampling Arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit.1.6. Integral filter unit intended for leukocyte reduction of Whole Blood up to 8 hours after blood collection when Whole Blood is stored at ambient temperature.

2. Dosage And Administration

2.1. Prepare the blood bag following your institution's standard operating procedures.2.2.1. Materials Needed : Evacuated blood collection tubes (glass or plastic)2.2. Make a loose knot in the donor tubing below the "Y" and CLIKTIP® (inline closure device) unless alternate methods are used to seal the tubing at the end of collection.2.3. Temporarily clamp donor tubing between the phlebotomy needle and the "Y".2.4. Suspend the collection bag as far as possible below the donor's arm.2.5. Apply blood pressure cuff or tourniquet to donor's arm. Disinfect site of phlebotomy. If blood pressure cuff is used, inflate to approximately 60 mmHg.2.6. Remove the needle cover and perform phlebotomy. Remove the temporary clamp on the donor tubing to permit blood flow into the Diversion Blood Sampling Arm pouch.2.6.1. CAUTION: Do not touch the needle after removing the needle cover.2.7. Secure the needle safety device in place following the device instructions provided on the reverse side.2.8. Secure donor tubing to donor's arm.2.9. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly down. When the level of blood in the pouch is approximately in line with the notches, the diversion pouch is full. (Fig. 2a)2.9.1. NOTE: The approximate fill volume of the pouch at the notches is 35 mL.2.10. Permanently seal the tubing between the "Y" and the diversion pouch to maintain a closed system using an aluminum clip or a tube sealer approved for use with tubing connected to a donor (Fig. 2b).2.10.1. CAUTION: Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose.2.11. To initiate blood flow into the collection bag, break the CLIKTIP between the "Y" and the collection bag.2.12. To avoid clot formation, collect samples as soon as possible from the diversion pouch as follows (Fig. 2b).2.12.1. CAUTION: Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed.2.12.2. Break the CLIKTIP in the tubing below the pouch to open the pathway for sampling. (Fig. 2b)2.12.3. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly downward. Assure that any air in the pouch is at the top and will not enter the blood collection tubes.2.12.4. Open the Tube Holder lid and insert blood collection tube firmly into the tube holder; when full, remove sample tube from holder. Repeat to collect additional samples.2.12.5. NOTE: The pouch may be removed after the donor test samples are collected. A second seal must be made between the diversion pouch and the permanent seal prior to removing the pouch.2.13. Mix blood with anticoagulant in the collection bag and continue to mix at several intervals during collection and immediately after collection. If using an automated mixer, follow manufacturer's instructions.2.14. Collect labeled volume of blood 500 mL ±10%.2.15. When the desired amount of blood has been collected, seal the tubing or tighten the loose knot (white knot) prepared in Step 2.2. Make a second seal between the first seal or knot and the "Y". Various methods may be used to seal tubing.2.16. Release pressure on the donor's arm and remove the needle into the needle safety device following the device instructions provided on the reverse side. Sever the donor tubing between the two seals previously made below the CLIKTIP and "Y".2.16.1. CAUTION: Discard the Diversion Blood Sampling Arm and phlebotomy needle/donor tubing according to institutional standard operating procedures.2.17. Seal and remove donor tubing from collection bag or strip donor tubing as follows:2.17.1. To obtain a quality control prefiltration sample, strip blood from donor tubing into collection bag, mix well, and allow tubing to refill; repeat once. To prevent the blood from clotting in the tubing, work quickly as possible. Leave an adequate length of tubing containing the well-mixed anticoagulated whole blood attached to the collection bag.2.17.2. Or, to maximize collection recovery, strip the tubing, mix well and seal tubing close to the collection bag without refilling. To prevent the blood from clotting in the tubing, work quickly as possible. Remove tubing from collection bag.2.18. The blood filtration is executed according to the following operation. (see Fig.3 and Fig.4)2.18.1. NOTE: Wait 1 hour after collection before filtering. Filtration can be accomplished when blood is stored at room temperature for up to eight hours after collection.2.18.2. NOTE: The band guides used to bundle the coiled tubing to prevent entanglement during shipping should be removed prior to filtration (not depicted).2.19. Mix the unfiltered whole blood unit by inverting the collection bag #1 (pre-filter bag) several times.2.20. Hang the collection bag #1, and extend the filtration set to 85 ± 2.5 cm or 33.5 ± 1 inch. Verify that the filter is vertical and ensure all tubing is freely suspended. Position and support bags #2 on a flat surface (Fig. 4).2.20.1. NOTE: This distance is measured from the outlet of the collection bag to the position of the supported bags as indicated in Fig. 4.2.20.2. NOTE: Verify tubing has been removed from the tube guides and extends freely.2.21. Break the CLIKTIP at the outlet of the collection bag #1, and start filtration.2.21.1. CAUTION: Do not squeeze the collection bag during filtration.2.21.2. CAUTION: Do not squeeze or apply pressure on the filter while it is attached to the bag containing the filtered blood.2.21.3. CAUTION: If for any reason whole blood passes through the one-way valve, stop filtration immediately and consider the product as non-leukocyte reduced.2.22. Filtration ends when the collection bag is empty or blood flow has stopped. Close the WHITE clamp above the filter.2.23. Expel air through the bypass line and back into the empty collection bag #1 by holding the primary bag #2 upright so that the air will be closest to the ports. Gently squeeze the primary bag containing the leukoreduced whole blood until filtered blood reaches the "Y" below the filter. To ensure ease of air removal ensure primary bag #2 is below the filter outlet.2.24. Open the WHITE clamp.2.25. Recovery of filtered Whole Blood is complete when the collection bag and the inlet side of the filter have drained or blood flow has stopped. Close the WHITE clamp.2.26. Seal the tubing as close as possible to the "Y" below the filter and properly dispose of the filter and collection bag #1.2.27. Strip the post filter tubing into the primary bag #2, mix well, and allow tubing to refill; repeat once. Make an appropriate number of segments of anticoagulated blood for testing by sealing on or near the X marks. Leave segments attached to the filtered whole blood unit.2.28. Mix CPD solution and whole blood thoroughly.2.28.1. NOTE: Whole blood in CPD may be stored for up to 21 days at 1-6°C.

3. Dosage Forms And Strengths

3.1. 70 mL Citrate Phosphate Dextrose (CPD) anticoagulant USP for collection of 500 mL Whole Blood. Each 70 mL contains 1.79 g Dextrose (monohydrate) USP, 1.84 g Sodium Citrate (dihydrate) USP, 209 mg Citric Acid (anhydrous) USP, 156 mg Monobasic Sodium Phosphate (monohydrate) USP.

5. Warnings And Precautions

5.1. Rx ONLY.5.2. Do not use unless solutions are clear and free from particulates.5.3. Always inspect the blood bag set for leaks before use.5.4. Avoid excessive heat and direct sunlight. Protect from freezing.5.5. Recommended storage conditions: Room Temperature (15-30°C/59-86°F).5.6. It is normal to have condensation in the aluminum foil pack. If the amount of moisture is greater than expected, check for leaks from the fluid-filled components of the blood bag set.5.7. Use aseptic techniques.5.8. Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose.5.9. Do not touch needle after removing the needle cover.5.10. Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed.5.11. Discard the Diversion Blood Sampling Arm and phlebotomy needle/donor tubing according to institutional standard operating procedures.5.12. Each aluminum foil pack contains a sachet that absorbs oxygen and generates heat on contact with air. The sachet should be handled with caution.5.12.1. Do not open the oxygen absorber sachet.5.12.2. Dispose of the aluminum foil pack with the oxygen absorber sachet in the pack.5.12.3. Do not dispose of the aluminum foil pack containing the oxygen absorber sachet together with waste containing volatile or flammable material.5.13. Due to possible exposure to infectious agents in the handling of blood, take adequate precautions at all times to prevent exposure to and transmission of such agents. Follow your institution's standard operating procedures.

11. Description / Product Specifications

11.1. This blood bag system includes a 16 gauge × 1 1/2 inch (1.60 × 38 mm) needle with needle cover and a 500mL collection bag containing 70mL Citrate Phosphate Dextrose (CPD) anticoagulant. The Double blood bag set has one integrally attached empty primary bag.11.2. Blood bag collection set is the collection set with an Integral Diversion Blood Sampling Arm for obtaining donor samples prior to collection of the Whole Blood Unit.11.3. Blood bag collection set is also included a DonorCare® Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side.11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer).11.5. The blood bag has no components made of natural rubber latex.11.6. Tubing internal diameter (ID) nominal 3.0 mm.11.7. Tubing outer diameter (OD) nominal 4.4 mm.11.8. Tubing line maximum 16 segments available.

16. How Supplied/Storage And Handling

16.1. Single use only.16.2. Sterile and non-pyrogenic fluid path. Sterilized by steam. Opacity of the blood bag system may be observed. This is due to moisture absorption during the sterilization process. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.16.3. Use immediately after opening aluminum foil pack.16.4. A Safety Data Sheet (SDS) is not required for this product.

Storage And Handling

16.5. Recommended storage conditions: Room Temperature (15-30°C/59-86°F).16.6. Avoid excessive heat and direct sunlight. Protect from freezing.16.7. Each aluminum foil pack contains a sachet that absorbs oxygen and generates heat on contact with air. The sachet should be handled with caution.16.8. For the Double blood bag set, Code BB*LCD506A6 is supplied. 10/case.

Procedure For Use Of Donorcare® Needle Guard

This device is for use by trained individuals.Intended UseThe DonorCare® Needle Guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor.Single Use Only.Preparation1. Move the DonorCare on the tubing ensuring that it slides easily and the arrow is pointing toward the needle hub.2. Ensure that the three lock points on the DonorCare are locked closed.Whole Blood Collection3. Perform the phlebotomy as per your institution's standard operating procedures.4. Slide the DonorCare over the needle hub so that it covers approximately one half to two thirds of the needle hub.5. Stabilize the DonorCare to the arm by placing a piece of tape over the front end so that the tape does not extend over the front of the DonorCare.Withdrawal of NeedleImportantThe DonorCare must be held stationary while the needle is withdrawn into it.CautionThe needle must be fully shielded by DonorCare to prevent accidental injury.6. Hold gauze over the venipuncture site with finger tips without exerting pressure. Hold the sides of the DonorCare near the front with the index finger and thumb of the same hand.7. With the other hand, hold the donor tubing close behind the DonorCare.Note: A hemostat may be placed on the tubing behind the DonorCare when the blood collection is complete.This will help to prevent blood drops from forming.8. Pull tubing smoothly and swiftly with one motion until the needle is locked in place inside the DonorCare.9. Confirm that the needle is locked by:a. Listening for two 'clicks' as the needle is drawn into DonorCare.b. If the clicks are not heard as the needle is drawn into the DonorCare, continue to pull firmly on the tubing to assure needle is fully withdrawn into DonorCare.10. Visually check that the needle is fully shielded by DonorCare before removing from the donor's arm.11. Remove the tape from the DonorCare and arm.12. Apply pressure to the gauze covering the venipuncture site.WarningDo not place fingers at the opening of DonorCare after removal from the donor's arm.Difficult Phlebotomy (Examples may include: Slow blood flow, deep or fine vein, steep angle)It may be necessary to delay placing the DonorCare over the needle hub until the end of the blood collection. In such situations:Leave the DonorCare on the tubing behind the needle hub. At the end of the blood collection carefully remove the tape from the needle hub and slide the DonorCare over the hub so that it covers approximately one half to two thirds of the needle hub. Withdraw the needle into the DonorCare as stated in steps 6. through 12. above.Rx ONLYDonorCare is manufactured by ITL Corporation, Melbourne, Australia.DonorCare is a registered trademark of Noble House Group Pty. Ltd. CORPORATION.TERUMO CORPORATION44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU,TOKYO 151-0072, JAPAN© TERUMO CORPORATION December, 2018

* Please review the disclaimer below.

Previous Code
53877-009
Next Code
53882-001